Canmax Technologies Co

Canmax Technologies Co Net Debt/FCF

The Net Debt to Free Cash Flow Ratio of Canmax Technologies Co (300390.SZ) as of Oct 22, 2026 is -3.18. In the previous year, Net Debt to Free Cash Flow Ratio was -2.60 — a change of 22.47% (lower).

Net Debt/FCF

-3.18

YoY

22.47%

Last updated:

Net Debt to Free Cash Flow Ratio of Canmax Technologies Co is 2024 -3.18 . Net Debt to Free Cash Flow Ratio of Canmax Technologies Co was 2023 -2.60 . It decreases by 22.47% lower compared to the previous year.

The Canmax Technologies Co Net Debt/FCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Debt/FCF
Date
Net Debt/FCF
Jan 1, 2017
-2.52 CNY
Jan 1, 2018
-1.29 CNY
Jan 1, 2019
-0.24 CNY
Jan 1, 2020
1.14 CNY
Jan 1, 2021
-0.55 CNY
Jan 1, 2022
-1.10 CNY
Jan 1, 2023
-2.60 CNY
Jan 1, 2024
-3.18 CNY
The Canmax Technologies Co Net Debt/FCF history
YEARNet Debt/FCFYoY
-3.18+22.47%
-2.60+135.32%
-1.10+99.31%
-0.55-148.59%
1.14-576.27%
-0.24-81.53%
-1.29-48.71%
-2.52-278.22%
1.42-67.30%
4.33-103.82%
-113.45—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Canmax Technologies Co Stock analysis

What does Canmax Technologies Co do? Canmax Technologies Co., Ltd. generates revenue through three core business segments. The Anti-static Ultra-clean Product segment sells human body protection systems, process protection systems, and environmental protection systems for cleanroom and ESD control. The Medical Device Product segment offers self-destruction syringes, safety syringes, and high pressure syringes. The Lithium Battery Material Product segment focuses on battery-grade lithium hydroxide, covering R&D, production, and sales. Domestic and overseas markets are the primary sales channels for all product lines. The company's customers include manufacturers requiring cleanroom solutions, healthcare providers needing medical devices, and battery producers seeking lithium hydroxide. These segments serve distinct industries: cleanroom and ESD control for electronics manufacturing, medical devices for healthcare, and battery materials for energy storage. The firm's product portfolio targets specific industrial needs within these sectors. Revenue streams are derived from the sale of anti-static ultra-clean products, medical devices, and lithium hydroxide. The Anti-static Ultra-clean Product segment supports electronics manufacturing with specialized systems, while the Medical Device Product segment caters to healthcare safety standards. The Lithium Battery Material Product segment meets demand for battery-grade lithium hydroxide in the growing energy storage market. Canmax Technologies Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Canmax Technologies Co stock

Net Debt to Free Cash Flow Ratio of Canmax Technologies Co is -3.18 in 2024.

Net Debt to Free Cash Flow Ratio of Canmax Technologies Co changed from -2.60 to -3.18, representing a 22.47% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Net Debt to Free Cash Flow Ratio Canmax Technologies Co since 2006 – with annual values, charts, and detailed analysis.

Net Debt/FCF indicates how many years it would take to repay net debt using free cash flow. Lower ratios suggest faster deleveraging potential.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Net Debt to Free Cash Flow Ratio's Canmax Technologies Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Leverage — Canmax Technologies Co

Debt-to-EquityNet Debt / EBITDAInterest CoverageCurrent RatioQuick RatioCash RatioDebt / AssetsFinancial LeverageEquity RatioLT Debt/EquityNet Debt/EquityDebt/EBITDADSCRFinancial Debt RatioOCF/DebtFCF/DebtNet Debt/FCFDebt/Market Cap

All Key Metrics — Canmax Technologies Co